Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedFooter revision updated to Revision: v3.3.3, and HHS Vulnerability Disclosure and Revision: v3.3.2 links were removed.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedMinor revision update from v3.3.1 to v3.3.2; no impact on study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedPublications section updated to indicate entries are automatically filled from PubMed and may not be about the study, and the revision tag updated to v3.3.1.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page no longer displays the temporary notice about government funding lapses and NIH Clinical Center operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check66 days agoChange DetectedNo significant changes detected in the page content or structure; essential study information remains the same.SummaryDifference0.4%

- Check95 days agoChange DetectedCore page metadata updated: new contact details added and version bumped from v3.0.2 to v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.